亚太地区结直肠癌诊断市场预测至 2028 年 - COVID-19 影响和区域分析 - 按方式 [成像测试（结肠镜检查、CT 结肠镜检查、柔性乙状结肠镜检查、胶囊内窥镜检查等）和粪便测试（粪便免疫化学测试 (FIT)） 、基于愈创木脂的粪便潜血测试和粪便 DNA 测试）]和最终用户（医院、诊断实验室、癌症研究机构等）
No. of Pages: 151 | Report Code: BMIRE00028831 | Category: Life Sciences
No. of Pages: 151 | Report Code: BMIRE00028831 | Category: Life Sciences
结直肠癌是一种在结肠或直肠组织中发生的恶性肿瘤。结直肠癌对亚洲国家人口的影响越来越大。根据国际癌症与研究机构的数据， GLOBOCAN，2020 年亚洲报告了约 100 万新结直肠癌病例。日本、中国、马来西亚、新加坡、韩国和土耳其报告的患病率高于亚太地区其他国家。手术是所有阶段结肠癌最常见的治疗方法。在理想情况下，如果癌症在早期被诊断出来，医生可以通过外科手术切除肿瘤。结肠镜检查是结直肠癌诊断的重要筛查测试，已成为常规癌症筛查的一部分。因此，结直肠癌患病率的上升推动了亚太结直肠癌诊断市场的增长。
亚太地区结直肠癌诊断市场分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。根据一项题为“中国结直肠癌筛查：现状、挑战和前景”的研究，结直肠癌（CRC）在 2022 年中国诊断最多的癌症中排名第三。根据 GLOBOCAN，预计新诊断结直肠癌病例为 555,477 例，新诊断结直肠癌病例为 286,162 例。 2020年中国结直肠癌相关死亡病例数随着人口老龄化、社会经济发展和生活方式的改变，近几十年来中国结直肠癌负担不断加重，尤其是城市和东部地区。研究表明，通过筛查早期发现和治疗结直肠癌及其癌前病变，可有效降低结直肠癌的死亡率和发病率。由于我国人口众多、医疗资源有限，大多数结直肠癌筛查项目均采用两级筛查策略。它采用无创或微创方法来选择高危人群和应接受结肠镜检查的人群（结直肠癌筛查的金标准）。中国大多数指南建议对 50 岁至 75 岁之间的平均风险人群进行结肠镜检查、软式乙状结肠镜检查或粪便潜血检测（主要是 FIT）。也在一些指南中得到推荐或通过共识。 2022 年 8 月，Pillar Biosciences 获得中国国家药品监督管理局批准其 OncoReveal Dx 结肠癌检测试剂盒商业化。此次批准对于中国各地的肿瘤学家来说非常重要，他们需要一种精简、高效、准确的方法来为患者确定正确的治疗方法。
由于社会经济的快速发展，环境问题、生活方式的改变和城市化，中国人在维持和改善健康方面面临着一些障碍。中国政府公布了“健康中国2030”规划纲要，强调健康对中国发展的战略重要性。卫生领域不断增长的投资和结肠癌患病率的上升正在推动中国亚太地区结直肠癌诊断市场的增长。
亚太地区结直肠癌诊断市场细分
亚太地区结直肠癌诊断市场按模式、最终用户和国家/地区进行细分。
根据模式，亚太结直肠癌诊断市场分为影像学测试和粪便测试。 2023年，影像测试领域在亚太结直肠癌诊断市场中占据更大份额。影像测试市场进一步细分为结肠镜检查、CT结肠造影、柔性乙状结肠镜检查、胶囊内窥镜检查等。基于粪便的测试市场细分为粪便免疫化学测试 (fit)、基于愈创木脂的粪便潜血测试 (gFOBT) 和粪便 DNA 测试。
基于对于最终用户，亚太结直肠癌诊断市场分为医院、诊断实验室、癌症研究机构等。 2023年，医院细分市场在亚太结直肠癌诊断市场中占据最大份额。
按国家/地区划分，亚太结直肠癌诊断市场分为中国、日本、印度、澳大利亚、韩国和亚太其他地区。 2023年，中国占据亚太结直肠癌诊断市场最大份额。
Medtronic Plc、Illumina Inc、Epigenomics AG、Clinical Genomics Technologies Pty Ltd、F. Hoffmann -La Roche Ltd、Quest Diagnostics Inc、Siemens Healthineers AG、Bruker Corp 和 Eiken Chemical Co., Ltd. 是亚太结直肠癌诊断市场的领先公司。
Strategic insights for Asia Pacific Colorectal Cancer Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 2,461.75 Million |
| Market Size by 2028 | US$ 3,859.28 Million |
| Global CAGR (2023 - 2028) | 9.4% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2028 |
| Segments Covered |
By 方式
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Colorectal Cancer Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Colorectal Cancer Diagnostics Market is valued at US$ 2,461.75 Million in 2023, it is projected to reach US$ 3,859.28 Million by 2028.
As per our report Asia Pacific Colorectal Cancer Diagnostics Market, the market size is valued at US$ 2,461.75 Million in 2023, projecting it to reach US$ 3,859.28 Million by 2028. This translates to a CAGR of approximately 9.4% during the forecast period.
The Asia Pacific Colorectal Cancer Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Colorectal Cancer Diagnostics Market report:
The Asia Pacific Colorectal Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Colorectal Cancer Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Colorectal Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Colorectal Cancer Diagnostics Market
